Lv1
88 积分 2024-04-07 加入
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial
19天前
已关闭
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial
19天前
已完结
Radiosynthesis of the iodine‐124 labeled Hsp90 inhibitor PU‐H71
21天前
已完结
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
22天前
已完结
HSP90 inhibitors beyond oncology: optimization and mechanism insights in non-oncological diseases
1个月前
已完结
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
1个月前
已完结
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
1个月前
已完结
The landscape for radioligand therapies in oncology
3个月前
已完结
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
3个月前
已完结
皖公网安备34019202002308
